S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
NASDAQ:MRNA

Moderna Short Interest Ratio and Short Volume

$70.55
+1.08 (+1.55 %)
(As of 09/28/2020 04:44 PM ET)
Add
Compare
Today's Range
$69.10
Now: $70.55
$71.50
50-Day Range
$54.34
MA: $66.60
$75.80
52-Week Range
$13.53
Now: $70.55
$95.21
Volume7.32 million shs
Average Volume17.72 million shs
Market Capitalization$27.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.47

Short Interest

Moderna (NASDAQ:MRNA) Short Interest Data

Current Short Volume:28,220,000 shares
Previous Short Volume:28,020,000 shares
Change Vs. Previous Month:+0.71%
Dollar Volume Sold Short:$1.96 billion
Short Interest Ratio / Days to Cover:1.0
Last Record Date:September, 15 2020
Outstanding Shares:329,010,000 shares
Float Size:322,210,000 shares
Short Percent of Float:8.76%
Today's Trading Volume:7,322,437 shares
Average Trading Volume:17,723,029 shares
Today's Volume Vs. Average:-58.68%



Moderna (NASDAQ:MRNA) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/15/202028,220,000 $1.96 billion 0.7%8.8%1.4$69.47
8/31/202028,020,000 $1.63 billion -11.5%8.7%1.4$58.29
8/14/202031,660,000 $2.00 billion 16.4%9.9%1.4$63.32
7/31/202027,190,000 $1.88 billion 10.0%8.7%1$68.96
7/15/202024,710,000 $1.83 billion -13.7%8.0%1$74.10
6/30/202028,640,000 $2.10 billion -0.4%9.7%1.4$73.21
6/15/202028,760,000 $1.77 billion 25.8%9.8%1.4$61.44
5/29/202022,860,000 $1.48 billion 14.4%8.3%1.1$64.84
5/15/202019,980,000 $1.23 billion -10.0%8.5%0.9$61.50
4/30/202022,200,000 $1.16 billion -7.0%11.1%1.2$52.18
4/15/202023,880,000 $1.60 billion 0.9%12.0%1.5$66.90
3/31/202023,660,000 $1.19 billion 10.9%11.9%1.8$50.50
3/13/202021,327,300 $679.49 million 5.8%9.5%1.4$31.86
2/28/202020,150,000 $535.39 million 17.6%8.9%2.3$26.57
2/14/202017,130,000 $382.68 million -8.6%7.8%3.1$22.34
1/31/202018,750,000 $546.75 million -7.0%9.3%7$29.16
1/15/202020,160,000 $430.42 million 6.2%10.0%9.6$21.35
12/31/201918,990,000 $401.07 million 29.9%9.4%11.8$21.12

Moderna (NASDAQ:MRNA) Short Interest FAQ

speech bubbles
speech bubbles











What is Moderna's current short interest?

Short interest is the volume of Moderna shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 28,220,000 shares of MRNA short. 8.76% of Moderna's shares are currently sold short. View details.

What is a good short interest ratio for Moderna?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Moderna currently has a short interest ratio of 1.0.

What is a good short interest percentage for Moderna?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.76% of Moderna's floating shares are currently sold short.

Is Moderna's short interest increasing or decreasing?

Moderna saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 28,220,000 shares, an increase of 0.7% from the previous total of 28,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Moderna's float size?

Moderna currently has issued a total of 394,587,000 shares. Some of Moderna's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moderna currently has a public float of 322,210,000 shares.

How does Moderna's short interest compare to its competitors?

8.76% of Moderna's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Moderna: Gilead Sciences, Inc. (1.44%), Biogen Inc (2.33%), Seattle Genetics, Inc. (0.00%), NOVOZYMES A/S/S (0.00%), BioNTech SE (0.00%), Qiagen NV (1.95%), argenx SE - (0.00%), BIO-TECHNE Corp (0.00%), Neurocrine Biosciences, Inc. (0.00%), and Repligen Co. (2.95%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.17 billion), Aon PLC ($3.57 billion), ViacomCBS Inc. ($3.01 billion), Clorox Co ($2.91 billion), Charles Schwab Co. ($2.80 billion), Mercadolibre Inc ($2.33 billion), Analog Devices, Inc. ($2.14 billion), Kroger Co ($1.99 billion), Moderna Inc ($1.96 billion), and Simon Property Group Inc ($1.80 billion). View all of the most shorted stocks.

What does it mean to sell short Moderna stock?

Short selling MRNA is an investing strategy that aims to generate trading profit from Moderna as its price is falling. Moderna's stock is trading up $1.08 today. To short Moderna stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Moderna will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Moderna?

A short squeeze for Moderna occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNA, which in turn drives the price of the stock up even further.

How often is Moderna's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNA, twice per month. The most recent reporting period available is September, 15 2020.


This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.